drugset / Trial / NCT01083264
Relative Bioavailability, Transdermally Administered EE and GSD, 3 Applications Sites
RandomizedCrossoverOpen-labelTreatment
Summary
Influence of different application sites on the blood levels after administration of a fertility control patch
Timeline
- Start
- 2009-10
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gestodene | Small molecule | 2.1 mg | Other |
| Subject | ethinyl estradiol | Small molecule | 0.55 mg | Other |
Indications
No indication recorded.